早些时候,我们知道他汀类药物能够抑制胆固醇合成中的一种关键酶。这类能够使心血管疾病或者有心血管疾病危险的人们受益的药物,其作用就是源于这种性质,而且是仅由这种性质决定的。环氧化酶-2型(COX-2)抑制剂有选择性的抗炎活性,不会对胃肠道产生不良作用,但其性质并不明确。随后的研究发现COX-2抑制剂存在一些问题,同时新的证据没有显示他汀类药物有什么危害。标志着抗炎活性的C反应蛋白水平的降低,表明他汀 Earlier, we learned that statins can inhibit a key enzyme in cholesterol synthesis. The role of such drugs that can benefit people at risk of cardiovascular disease or cardiovascular disease stems from this nature and is determined only by this nature. Cyclooxygenase-2 (COX-2) inhibitors have selective anti-inflammatory activity with no adverse effects on the gastrointestinal tract, but their nature is not clear. Subsequent studies found some problems with COX-2 inhibitors, and new evidence did not show any danger of statins. The decrease in C-reactive protein, which indicates anti-inflammatory activity, suggests statin